Editorial policy
Health content earns trust in public.
We separate editorial explanation from clinical decisions. We label what is known, what is uncertain, and what is not yet available. This page explains how.
Where our facts come from.
We use sources in this order, and we link them next to the claims they support.
- FDA labels, safety communications, databases and official guidance.
- NIH, CDC, CMS, state boards and other government sources.
- Peer-reviewed systematic reviews, guidelines and pivotal trials.
- Specialty-society guidance.
- Partner documentation, for operational facts only.
- Competitor pages, for market observations only — never as medical evidence.
Every claim will be logged.
We are building a claim ledger for every medical page. It will record the exact claim, the population, formulation, route, dose and outcome, the source, the evidence grade, the reviewer and the re-review date. Until it is complete, every claim links to its source on the page.
A claim does not ship if the evidence is about a different ingredient, dose, route, population or outcome — unless the page states that limit plainly, next to the claim.
How a page is reviewed.
- Brief and research from primary sources.
- Writing and plain-language edit.
- Medical review against the claim ledger.
- Legal and compliance review where required.
- Accessibility and quality checks, then publication.
- A performance and accuracy check at 30, 90 and 180 days.
TODO(clinical) Our medical reviewer is not engaged yet. Until then, every page shows its medical review as pending. See the review status.
Rules we do not bend.
- We never call a compounded drug FDA-approved, generic, equivalent, identical or a substitute for a brand.
- We never say a pharmacy or facility is "FDA approved".
- We never imply guaranteed eligibility, prescription, delivery time or result.
- We do not publish testimonials, before-and-after photos, invented reviewers or invented prices.
- We put limits next to the claims they qualify.
Corrections and updates.
We fix errors when we find them and say what changed. After an FDA warning, a recall, an availability change, a partner change or a material legal correction, we update affected pages within one business day.
We review pricing, state availability, pharmacy, partner and product-status facts at least monthly. To report an error, email [email protected].
How we use AI tools.
We may use AI tools to help research and draft. A person edits every page and checks every source. No page is marked medically reviewed until a clinician has reviewed it.
Conflicts and advertising.
Livozo expects to offer clinician-reviewed access to some treatments we write about, through a licensed clinical partner. We disclose this on the pages where it applies. Our guides do not rank providers for payment, and no advertiser can buy or change editorial content.